Emerald Advisers, LLC reported 224 positions worth $3.64B for the quarter ended Sep 30, 2026, down 14.3% on the prior quarter. It opened 15 new positions, added to 93, trimmed 100 and exited 28. Its largest holding is Travere Therapeutics, Inc. at 2.5% of the portfolio.
Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.
Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.
How many positions were opened, added to, trimmed or closed each quarter.
Share of reported value in each sector at every quarter end.
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| PRAX Praxis Precision Medicines, Inc. | +110.8K | – | $32.26M | 0.886% |
| REPL Replimune Group, Inc. | +2.04M | – | $27.03M | 0.742% |
| RDVT Red Violet, Inc. | +312.3K | – | $24.67M | 0.677% |
| AXTI Axt Inc | +312.2K | – | $24.17M | 0.664% |
| FEIM Frequency Electronics Inc | +279.4K | – | $23.61M | 0.648% |
| NEO Neogenomics Inc | +1.20M | – | $22.07M | 0.606% |
| MXL Maxlinear, Inc | +180.7K | +64.5% | $16.32M | 1.14% |
| AEHR Aehr Test Systems | +161.1K | – | $16.05M | 0.441% |
| BTSG BrightSpring Health Services, Inc. | +264.4K | – | $15.00M | 0.412% |
| HRMY Harmony Biosciences Holdings, Inc. | +351.3K | – | $13.79M | 0.379% |
| Holding | Change | Change % | Trade Value | Weight |
|---|---|---|---|---|
| SYNA SYNAPTICS Inc | -298.6K | -100.0% | $37.09M | Exited |
| MOD Modine Manufacturing Co | -194.6K | -96.0% | $36.44M | 0.042% |
| RMBS Rambus Inc | -252.7K | -100.0% | $33.54M | Exited |
| TTMI Ttm Technologies Inc | -219.2K | -98.9% | $26.92M | <0.01% |
| MIR Mirion Technologies, Inc. | -1.36M | -100.0% | $24.47M | Exited |
| HIMS Hims & Hers Health, Inc. | -608.5K | -100.0% | $21.10M | Exited |
| CCB Coastal Financial Corp | -216.3K | -100.0% | $16.77M | Exited |
| ONTO Onto Innovation Inc. | -54.2K | -61.9% | $16.69M | 0.282% |
| GH Guardant Health, Inc. | -90.4K | -24.8% | $16.12M | 1.34% |
| VC Visteon Corp | -162.4K | -100.0% | $16.11M | Exited |
| Holding | Shares | Trade Value | Weight |
|---|---|---|---|
| PRAX Praxis Precision Medicines, Inc. | +110.8K | $32.26M | 0.886% |
| REPL Replimune Group, Inc. | +2.04M | $27.03M | 0.742% |
| RDVT Red Violet, Inc. | +312.3K | $24.67M | 0.677% |
| AXTI Axt Inc | +312.2K | $24.17M | 0.664% |
| FEIM Frequency Electronics Inc | +279.4K | $23.61M | 0.648% |
| NEO Neogenomics Inc | +1.20M | $22.07M | 0.606% |
| AEHR Aehr Test Systems | +161.1K | $16.05M | 0.441% |
| BTSG BrightSpring Health Services, Inc. | +264.4K | $15.00M | 0.412% |
| HRMY Harmony Biosciences Holdings, Inc. | +351.3K | $13.79M | 0.379% |
| SNEX StoneX Group Inc. | +131.3K | $8.49M | 0.233% |
| Holding | Shares Sold | Trade Value | Prior Weight |
|---|---|---|---|
| SYNA SYNAPTICS Inc | -298.6K | $37.09M | 0.873% |
| RMBS Rambus Inc | -252.7K | $33.54M | 0.789% |
| MIR Mirion Technologies, Inc. | -1.36M | $24.47M | 0.576% |
| HIMS Hims & Hers Health, Inc. | -608.5K | $21.10M | 0.497% |
| CCB Coastal Financial Corp | -216.3K | $16.77M | 0.395% |
| VC Visteon Corp | -162.4K | $16.11M | 0.379% |
| TREE LendingTree, Inc. | -334.7K | $14.82M | 0.349% |
| AVEX AEVEX Corp. | -538.6K | $11.25M | 0.265% |
| DFTX Definium Therapeutics, Inc. | -178.8K | $8.41M | 0.198% |
| FLOC Flowco Holdings Inc. | -382.1K | $8.15M | 0.192% |
| # | Activity | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | TVTX Travere Therapeutics, Inc. | Healthcare | 1.56M | $92.06M | 2.53% | -37.4K | -2.3% | Reduced | 1.63% |
| 2 | CORT Corcept Therapeutics Inc | Healthcare | 758.3K | $87.37M | 2.4% | +9,932 | +1.3% | Added | 0.69% |
| 3 | IDCC InterDigital, Inc. | Technology | 226.4K | $73.83M | 2.03% | +2,910 | +1.3% | Added | 0.88% |
| 4 | SXT Sensient Technologies Corp | Basic Materials | 467.2K | $61.08M | 1.68% | +72.3K | +18.3% | Added | 1.1% |
| 5 | COHU Cohu Inc | Technology | 836.6K | $57.01M | 1.57% | -7,025 | -0.8% | Reduced | 1.66% |
| 6 | SMTC Semtech Corp | Technology | 306.5K | $54.66M | 1.5% | -86.6K | -22.0% | Reduced | 0.33% |
| 7 | PLXS Plexus Corp | Technology | 208.2K | $54.34M | 1.49% | +534 | +0.3% | Added | 0.78% |
| 8 | MRCY Mercury Systems Inc | Industrials | 644.2K | $53.46M | 1.47% | +5,471 | +0.9% | Added | 1.08% |
| 9 | VSEC Vse Corp | Industrials | 322.4K | $53.09M | 1.46% | -781 | -0.2% | Reduced | 1.02% |
| 10 | CECO Ceco Environmental Corp | Industrials | 748.7K | $52.14M | 1.43% | +11.9K | +1.6% | Added | 1.28% |
| 11 | LIVN LivaNova PLC | Healthcare | 678.5K | $51.90M | 1.43% | -108.6K | -13.8% | Reduced | 1.23% |
| 12 | COGT Cogent Biosciences, Inc. | Healthcare | 1.61M | $51.67M | 1.42% | +10.2K | +0.6% | Added | 0.93% |
| 13 | KLIC Kulicke & Soffa Industries Inc | Technology | 545.3K | $51.40M | 1.41% | -6,190 | -1.1% | Reduced | 1.04% |
| 14 | SYRE Spyre Therapeutics, Inc. | Healthcare | 571.0K | $50.84M | 1.4% | +3,617 | +0.6% | Added | 0.65% |
| 15 | AIR Aar Corp | Industrials | 500.2K | $50.75M | 1.39% | -21.8K | -4.2% | Reduced | 1.24% |
Tip. Select a row to see that position’s full history at Emerald Advisers.
As of its Q3 2026 13F filing, Emerald Advisers, LLC’s five largest positions were Travere Therapeutics, Inc. (TVTX) at 2.5%, Corcept Therapeutics Inc (CORT) at 2.4%, InterDigital, Inc. (IDCC) at 2.0%, Sensient Technologies Corp (SXT) at 1.7%, Cohu Inc (COHU) at 1.6% of the reported portfolio.
Emerald Advisers, LLC reported a 13F portfolio worth $3.64B across 224 positions for Q3 2026. That is down 14.3% from the previous quarter.
Its largest purchases by value were Praxis Precision Medicines, Inc. ($32.26M), Replimune Group, Inc. ($27.03M), Red Violet, Inc. ($24.67M). It opened 15 new positions.
Its largest sales by value were SYNAPTICS Inc ($37.09M), Modine Manufacturing Co ($36.44M), Rambus Inc ($33.54M). It exited 28 positions entirely.
From the Form 13F-HR reports Emerald Advisers, LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.
13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.